NorCRIN user meeting, 25 September 2017 – programme and presentations

NorCRIN user meeting, 25 September 2017, the Norwegian Radium Hospital, Oslo

Meeting Chair: Ernst Omenaas, Head of Research, Bergen Health Trust/Western Norway Regional Health Authority

Programme and agenda

09.30–10.00 Coffee and registration

10.00–11.20 What is NorCRIN, and what contribution does it make?

• Welcome by Board Chair Kristin Bjordal (OUS) and Project Manager Siv Mørkved (St. Olav)
  • What is NorCRIN?
  • Who are NorCRIN’s users?
• What is the goal of NorCRIN?
• Work packages – examples presented by Martha Colban (OUS), Lisbeth Johnsen (Ahus), Sameline Grimsgaard (UNN)
• Example of how NorCRIN is used, by Network Coordinator Sigrun K. Sæther (St. Olav)
• ECRIN (European Clinical Research Infrastructure Network), by Ola Dale (St. Olav)
• Questions

11.20–11.35 Break

11.35–12.10 Expectations for NorCRIN

• HOD – Research Director Maiken Engelstad
• Research Council of Norway – Senior Adviser Henrietta Blankson
• LMI – Senior Adviser Katrine Bryne

12.10–12.20 Clinical Research Initiative for Global Health (CRIGH) – opportunities for Norway

• The Norwegian Directorate of Health – Senior Adviser Øyvind Melien

12.20–13.00 LUNCH

13.00–13.15 User participation, an example (patient’s perspective)

13.15–13.30 A safe hand to hold, seen from a monitor’s typical day, by Ingunn Aanundskås (HUS)

13.30–15.30 Clinical trials, user experience and NorCRIN

• Introduction by Ola Dale (St. Olav)
• Kaare Bønaa: Trialling medical technical equipment: The Nor-stent study: How was it possible to achieve? Critical events? How was GCP addressed?
• Guro Løvik Goll: Nor-Switch: The significance of GCP and benefit of NorCRIN.
• Arne Skulberg: From GP to “GCP nerd”
• Rebecca Jane Cox: Researcher-initiated influenza vaccine trial in children – collaboration between lab, surgery and research post

    Exchange of experience (and coffee)

    Panel discussion – Possible topics:

• GCP in trialling technical equipment versus trials of medicinal products
• Is it possible to finance long-term clinical trials in Norway?
• How is it possible to attract more clinical trials in children?
• Multicentre trials – what research support is needed?

15.30–16.00 Summary